Biocon has informed that it enclosed the press release titled ‘Biocon Biologics Collaborates with RSSDI to Expand Access to its Insulins for Children with Type 1 Diabetes on World Diabetes Day.’ The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.